Showing results (81-90 of 235) with videos related to
Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C AppelbaumThe Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C AppelbaumThe Journal of Antimicrobial Chemotherapy|August 1, 1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactamP C Appelbaum, S K Spangler, M R JacobsJournal of Clinical Microbiology|June 1, 1985
Accuracy and reproducibility of a four-hour method for anaerobe identificationP C Appelbaum, C S Kaufmann, J W DepenbuschJournal of Clinical Microbiology|November 18, 1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C AppelbaumEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C AppelbaumEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C AppelbaumPageof 24